MPFFPSDC: A multi-pooling feature fusion model for predicting synergistic drug combinations

Methods. 2023 Sep:217:1-9. doi: 10.1016/j.ymeth.2023.06.006. Epub 2023 Jun 14.

Abstract

Drug combination therapies are common practice in the treatment of cancer, but not all combinations result in synergy. As traditional screening approaches are restricted in their ability to uncover synergistic drug combinations, computer-aided medicine is becoming a increasingly prevalent in this field. In this work, a predictive model of potential interactions between drugs named MPFFPSDC is presented, which can maintain the symmetry of drug inputs and eliminate inconsistencies in predictive results caused by different drug inputting sequences or positions. The experimental results show that MPFFPSDC outperforms comparative models in major performance indicators and exhibits better generalization for independent data. Furthermore, the case study demonstrates that our model can capture molecular substructures that contribute to the synergistic effect of two drugs. These results indicate that MPFFPSDC not only offers strong predictive performance, but also has good model interpretability that may provide new insights for the study of drug interaction mechanisms and the development of new drugs.

Keywords: Attention mechanism; Combination therapy; Graph neural network; Model interpretability; Synergism prediction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Combinations
  • Drug Interactions
  • Drug Synergism
  • Drug Therapy, Combination
  • Humans
  • Neoplasms* / drug therapy

Substances

  • Drug Combinations